74 results about "Platelet adhesion" patented technology

The invention belongs to the technical field of biological medicines, and particularly relates to hydrogel with photo-thermal multiple antibacterial and hemostatic functions. The multifunctional hydrogel is prepared from epsilon-polylysine (EPL), gallic acid (GA), tannic acid (TA) and ferric trichloride hexahydrate. The polyphenols are obtained through multiple mechanisms such as reaction between the polyphenols and amino groups, metal chelation, pi-pi interaction and electrostatic attraction (as shown in Figure 1). The metal ion and multiple dynamic cross-linking system hydrogel is constructed, the hydrogel with positive charges enriched on the surface can act with blood platelets with negative charges, red blood cell aggregation, blood platelet adhesion and vasoconstriction effects are promoted, and the blood coagulation efficiency is improved. The hydrogel shows excellent antibacterial performance and photo-thermal performance, can prevent infection in the inflammation stage of wound healing, can effectively accelerate wound healing, and has good biological safety.

The invention relates to the technical field of coating surface preparation, in particular to an anticoagulant coating based on novel tick-derived anticoagulant protein Qinghaenin and a preparation method of the anticoagulant coating. The functional layer of the anticoagulant coating comprises the following components: anticoagulant protein Qinghaenin or a functional peptide fragment Qinghaenin 167-192 of the anticoagulant protein Qinghaenin, wherein the amino acid sequence of the functional peptide fragment is as shown in SEQ ID NO. 2. The preparation method of the anticoagulant coating comprises the following steps: by using a polydopamine coating as a substrate layer, covalently grafting through an amido bond, immobilizing anticoagulant protein Qinghaenin capable of inhibiting FXII factor activation or a functional peptide fragment Qinghaenin 167-192 thereof on the surface of a medical polymer material, and successfully constructing a novel anticoagulant coating. Compared with an unmodified medical polymer material, the modified coating can significantly enhance the hydrophilic performance of the material and inhibit platelet adhesion and activation, finally effectively prolongs the in-vitro blood coagulation time, and shows excellent anticoagulation performance.

The invention relates to the technical field of medical artificial intelligence, in particular to a vascular embolism risk prediction method based on big data analysis, and the method comprises the steps: collecting a pulse pressure fluctuation rate, a microcirculation resistance index and a platelet adhesion gradient through a multi-source sensor, and extracting dynamic physiological parameter time sequence features; constructing a hemodynamic finite element model based on CTA and VFI image data, and obtaining a vascular mechanical feature vector; deep coupling of the pulse pressure spectrum and the circumferential stress is achieved through dynamic time warping and convolution mapping, and a multi-modal risk feature set is generated; and performing cross-modal coding by using the double-branch graph neural network, and outputting an acute embolism probability and a three-dimensional risk thermodynamic diagram. According to the method, physiological, image and mechanical multi-dimensional information is fused, and the method has the advantages of being high in real-time performance, accurate in positioning and good in interpretability and is suitable for risk prediction and auxiliary diagnosis of clinical cardiovascular and cerebrovascular events.

The invention discloses an antibacterial and antithrombotic medical catheter and a preparation method thereof. According to the medical catheter, a hydrogel coating is prepared on the surface of the medical catheter, the hydrogel coating contains a three-layer structure, and the medical catheter has low swelling property and excellent mechanical property, stability, durability, platelet adhesion resistance, antibacterial property and biocompatibility. The preparation method disclosed by the invention is simple, efficient and environment-friendly; the dopamine layer provides strong adhesion performance, glucose oxidase entrapped in FDA provides longer-term antibacterial performance, and finally the carboxylic acid betaine zwitterionic coating is introduced to further enhance the antithrombotic performance of the hydrogel coating, so that the hydrogel coating medical catheter is produced. The invention provides a new strategy for the low-expansion amphiphilic ion hydrogel coating with antithrombotic and antibacterial properties in the field of biomedical materials, especially as a medical catheter, and the coating can be applied to biomedical equipment in contact with blood.

The invention discloses an intracavity anchor, a preparation method thereof and a blood vessel occlusion device. Relates to the technical field of medical instruments, in particular to an intracavity anchor which comprises an anchor body and a medicine carrying coating, the surface of the anchor body is coated with the medicine carrying coating, and the medicine carrying coating comprises at least one of anti-platelet adhesion medicine, anti-coagulation medicine, anti-proliferation medicine and anti-infection medicine. The intracavitary anchor provided by the invention has excellent anticoagulation, anti-proliferation and anti-infection capabilities, can effectively reduce the generation of clinical complications, avoids the need of long-term medicine taking of patients, reduces the pain and risk of the patients during treatment, and further enables the vascular structure and function to recover to a healthy state as soon as possible.

The invention relates to the technical field of blood purification materials, in particular to a zirconium-titanium bimetal MOF hollow microsphere adsorbent and a preparation method and application thereof. The adsorbent is based on a Zr / Ti bimetallic node and a phosphonic acid-carboxylic acid mixed ligand, a composite MOF hollow microsphere structure with high stability and high specific surface area is constructed through a solvothermal and polymerization synergistic reaction in a water-in-oil suspension system, a phosphonic acid group and Zr are strongly coordinated to improve the stability of a framework, and the composite MOF hollow microsphere structure has a high specific surface area. The carboxylic acid group keeps the hydrophilicity of the pore channel; meanwhile, a cross-linked network of acrylamide and N, N '-methylene bisacrylamide penetrates through crystal gaps in the balling process, so that the material has excellent mechanical strength and fluid stability; and a sulphobetaine amphoteric polymer brush layer is constructed on the surface of the MOF through endogenous initiation point modification and surface in-situ controllable free radical polymerization technologies, so that protein adsorption and platelet adhesion are effectively inhibited, the blood compatibility is remarkably improved, and meanwhile, the channel accessibility is maintained to promote rapid diffusion and adsorption of bilirubin.

The invention belongs to the field of medicine, and relates to application of hyperoside and metabolite thereof in preparation of antiplatelet drugs, hyperoside or 3 '-O-methylated hyperoside in the application has inhibitory activity on PDI reductase, and can also directly inhibit platelet adhesion, platelet activity, blood clot contraction and the like.

The invention discloses a hemodialysis puncture needle device capable of reducing blood cell destruction, which comprises a puncture needle and a dialysis connecting tube, and is characterized in that the puncture needle comprises a needle seat and a needle tube, and the needle seat is arranged at one end of the needle tube; the dialysis connecting tube is connected to the needle seat and is used for conveying blood to the puncture needle; wherein the surface of the needle tube is provided with a heparin nano coating with the thickness of 0.5-1 mu m, and the heparin nano coating is used for reducing platelet adhesion; the needle tube comprises a main body section, a transition section and a puncture section which are connected in sequence, the inner diameter of the main body section is smaller than that of the transition section, the inner diameter of the transition section is smaller than that of the puncture section, and the main body section is connected to the needle seat. The heparin nano coating with the thickness of 0.5-1 micron is arranged on the surface of the needle tube, and the needle tube structure with the main body section, the transition section and the puncture section which are sequentially expanded in diameter is adopted, so that blood cell damage and platelet abnormal adhesion caused by direct contact of the surface of the metal needle tube in the hemodialysis process are remarkably reduced, and the risk of microthrombus generation is reduced.

The invention belongs to the technical field of medicines, and discloses application of pantethine in preparation of medicines for preventing and / or treating thrombotic diseases or medicines for inhibiting platelet activation or regulating vascular endothelial cell functions. In-vivo and in-vitro experiments prove that pantethine can remarkably relieve thrombus load in a mouse thrombus model, down-regulate expression of vWF (von Willebrand Factor), up-regulate expression of TFPI (Tissue Factor Path Inhibitor) and TH BD (Thromboregulatory Protein), and antagonize platelet adhesion, aggregation and activation induced by a platelet activator. The action mechanism is closely related to inhibition of reactive oxygen species (ROS) generation and NF-kappa B signal channel activation, and improvement of endothelial cell functions. It can be known from the invention that pantethine plays an antithrombotic role from multiple aspects, and is suitable for preparation of antithrombotic drugs for prevention or treatment. The invention provides a new drug choice for prevention and treatment of thrombotic diseases.

The utility model provides an extracorporeal circulation connecting tube for hemodialysis, which comprises a connecting tube body, the front end of the connecting tube body is communicated with a joint, the connecting tube body comprises a substrate layer, a first functional layer and a second functional layer, and the first functional layer comprising a polydimethylsiloxane coating and a heparin coating is arranged, so that the heparin coating is coated on the first functional layer, and the heparin coating is coated on the second functional layer. Wherein the polydimethylsiloxane coating reduces the interaction between the surface and blood components through the unique non-polarity and low surface energy characteristics of the polydimethylsiloxane coating, and can significantly reduce protein adsorption and platelet adhesion, so that the risk of thrombosis is reduced, the hemodialysis effect is improved, the blood vessel health of a long-term dialysis patient is maintained, and the treatment effect is improved. The heparin coating heparin is a substance with an anticoagulation function, the coating of the heparin coating forms an interface capable of active anticoagulation on the surface of the extracorporeal circulation connecting pipe, and the heparin coating not only reduces platelet aggregation and thrombin generation by being combined with antithrombin III (ATIII) in blood.

Described herein are methods for producing omniphobic coating compositions. The methods provide an extremely facile and economic synthetic process that can be extended to a wide range of substrates for widespread real-world applicability. The omniphobic coating compositions produced herein possess numerous advantageous properties including, but not limited to, high physical durability, aqueous chemical stability, thermal and UV resistance, prolonged room temperature storage, cytocompatibility and impeccable anti-biofouling properties including anti-platelet adhesion. In one aspect, the omniphobic coating composition is produced by the method comprising (a) functionalizing a surface of the article with a plurality of nucleophilic groups to produce a pre-functionalized surface, and (b) contacting the pre-functionalized surface with a perfluorolkylsiloxane comprising an electrophilic group, wherein the plurality of nucleophilic groups on the surface of the article react with the electrophilic group on the perfluoroalkylsiloxane to covalently bond the perfluoroalkylsiloxane to the surface of the article.

The present invention relates to a method for modifying and cross-linking an anticoagulating hydrogel nanofilm for cell encapsulation. According to the present invention, the protection from the external environment and the control of material transfer can be improved due to the anticoagulant functionalization of the material surface. In addition, when applied into the body, it can prevent fibrosis, blood coagulation, protein adsorption, and platelet adhesion caused by immune responses, thereby preventing a decrease in cell viability caused by immune responses and improving cell survival rate.

The application relates to the field of blood purification materials, and particularly discloses an anion exchange resin membrane applied to blood purification and a preparation method thereof. The anion exchange resin membrane applied to blood purification is prepared by blending a zwitterion-anion exchange copolymer and a hydrophobic film-forming polymer; the zwitterion-anion exchange copolymer is copolymerized by an anion exchange monomer and a zwitterion monomer, so that the resin membrane has anion exchange function and anti-protein adsorption function; the preparation method is as follows: the anion exchange monomer and the zwitterion monomer are subjected to free radical copolymerization under the action of an initiator; the copolymer and polyether sulfone are dissolved in a polar aprotic solvent to prepare a casting solution, and after casting film formation, phase inversion is completed by immersing in a coagulation bath; the obtained membrane is cleaned and subjected to alkalization treatment. The application solves the problems that traditional anion exchange resins easily cause non-specific protein adsorption, platelet adhesion and complement system activation.

A carboxylic acid-type lipid can accelerate adhesion or aggregation of platelets even if the carboxylic acid-type lipid does not carry a protein involved in adhesion or aggregation of platelets or a peptide corresponding to an active site of the protein; a lipid particle and a lipid membrane each include the carboxylic acid-type lipid; and a platelet aggregation accelerating agent, a platelet adhesion accelerating agent, a hemostatic agent and a platelet substitute each include the carboxylic acid-type lipid, the lipid particle or the lipid membrane. A carboxylic acid-type lipid is selected from carboxylic acid-type lipids represented by formulas (I) to (VI), a lipid particle includes the carboxylic acid-type lipid, a lipid membrane includes the carboxylic acid-type lipid, and a platelet aggregation accelerating agent, a platelet adhesion accelerating agent, a hemostatic agent and a platelet substitute each include the carboxylic acid-type lipid, the lipid particle or the lipid membrane.

The application relates to the technical field of coating surface preparation, in particular to an anticoagulant coating based on a novel tick-derived anticoagulant protein Qinghaienin and a preparation method thereof. 167‑192 Wherein the amino acid sequence of the functional peptide segment is shown in SEQ ID NO. 2. The anticoagulant coating is prepared by using a polydopamine coating as a base layer, and then covalently grafting the anticoagulant protein Qinghaienin or the functional peptide segment Qinghaienin 167‑192 which can inhibit the activation of the FXII factor is covalently grafted through an amide bond to the surface of a medical polymer material, and a novel anticoagulant coating is successfully constructed. Compared with unmodified medical polymer materials, the modified coating can significantly enhance the hydrophilicity of the material, inhibit platelet adhesion and activation, effectively prolong the blood clotting time in vitro, and exhibit excellent anticoagulant performance.

The invention relates to a blood pump with a microstructure super-hydrophobic surface, which comprises a blade and a super-hydrophobic coating coated on the surface of the blade, and a micron-sized periodic pit array is etched on the surface of the blade through a femtosecond laser texturing technology to form a microstructure. A micron-sized periodic pit array is etched on an interface, in contact with blood, of a blood pump through a femtosecond laser texturing technology, so that a bionic micro-nano composite structure is formed; and a super-hydrophobic functional layer is constructed on the surface of the microstructure by further adopting a multi-scale coating technology (including but not limited to a plasma enhanced chemical vapor deposition method, a high-speed oxygen fuel thermal spraying method, a photoetching template guided self-assembly method and a directional electrostatic spinning method). Zero damage of blood cells under the dynamic shearing condition can be achieved, meanwhile, platelet adhesion and blood coagulation factor activation are effectively inhibited, and a breakthrough solution is provided for solving related complications of artificial heart clinical application.

The application provides a platelet-responsive self-gelation hemostatic material and a preparation method and application thereof, and belongs to the medical field. Based on a multiple cross-linking strategy of dynamic covalent bonds and non-covalent interactions, a hemostatic material capable of realizing self-gelation quickly is designed by using modified sodium alginate and hydroxylated porcine small intestinal submucosa as raw materials. The hemostatic material has good hydrophilicity and liquid absorption capacity, can realize powder-gelation transformation in a short time, form a stable physical barrier, has platelet response characteristics, can promote platelet adhesion and activation, accelerate the blood coagulation process of the body, and improve the mechanical properties and tissue adhesion of the material, and has a good application prospect.

The invention discloses a polyurethane surface bionic coating capable of synergistically resisting blood coagulation and promoting endothelialization and a preparation method, and relates to the technical field of biomedical materials. According to the invention, tannic acid (TA) and polylysine (PLL) are subjected to a Schiff base and Michael addition reaction in a weak alkaline environment to form a covalent cross-linked bionic intermediate layer, and the intermediate layer synergistically loads heparin (Hep) and laminin (Ln) on the surface of polyurethane (PU) to form a multifunctional active coating, so that the polyurethane material with the bionic coating is formed. The surface coating of the polyurethane material significantly reduces platelet adhesion and hemolysis rate, promotes endothelial cell adhesion, proliferation and functional expression, and inhibits excessive proliferation of smooth muscle cells, and the polyurethane material is simple in preparation process, mild in condition and suitable for surface functional modification of blood contact materials such as artificial blood vessels and interventional catheters.

The present application discloses a SERS probe combination and kit and a method for identifying and / or quantifying platelet-adherent CTC. The probe combination comprises: a first probe comprising a nanoparticle, a Raman reporter molecule and a first recognition element comprising an agent that specifically recognizes a circulating tumor cell (CTC); and a second probe comprising a nanoparticle, a Raman reporter molecule and a second recognition element comprising an agent that specifically recognizes a platelet.

The invention provides a small-caliber artificial blood vessel and a preparation method thereof, and belongs to the technical field of biomedicine. The preparation method comprises the following steps: dissolving a solid polymer material in hexafluoroisopropanol to obtain a spinning solution A; polydeoxyribonucleotide and procyanidine are mixed and dissolved in water, and a spinning solution B is obtained; performing electrostatic spinning on the spinning solution A and the spinning solution B to obtain the small-caliber artificial blood vessel. The PDRN and the PC are used for preparing the small-caliber artificial blood vessel at the same time, the preparation process is simple, use is convenient, the production cost is low, and the prepared artificial blood vessel has good biocompatibility, can promote endothelialization of the blood vessel and has the effect of resisting platelet adhesion.

The invention discloses a preparation method of an expanded polytetrafluoroethylene (ePTFE) small-caliber artificial blood vessel based on directly grafted heparin of polydopamine nanoparticles. The method comprises the following steps: performing plasma treatment on a cleaned ePTFE small-caliber artificial blood vessel, grafting PDA-NPs on the treated artificial blood vessel, activating heparin by using EDCHCl and NHS, and reacting the ePTFE / PDA / HEP small-caliber artificial blood vessel grafted with the PDA-NPs with an activated heparin solution to obtain the heparin-grafted ePTFE / PDA / HEP small-caliber artificial blood vessel. And finally, washing and freeze-drying to obtain the artificial blood vessel. By utilizing the synergistic effect of plasma treatment and PDA-NPs modification, the loading capacity and stability of heparin are remarkably improved, the prepared artificial blood vessel has excellent anti-platelet adhesion performance, extremely low hemolysis rate and good biocompatibility, no toxic coupling agent needs to be added in the whole process, the safety is high, the process is stable, and the preparation method is suitable for industrial production. The method has a wide application prospect in the field of clinical transformation of small-caliber artificial blood vessels.

The invention relates to the technical field of medical polymer materials, and particularly discloses a nylon material for a medical catheter as well as a preparation method and application of the nylon material. The nylon material for the medical catheter is mainly prepared from the following raw materials in percentage by weight: 80-90% of nylon resin, 8-12% of organic grafted SEBS (Styrene-Ethylene-Butylene-Styrene) and 2-8% of an anticoagulant, the nylon resin is selected from nylon 12 and nylon 6, and the weight ratio of the nylon 12 to the nylon 6 is (6-8): (2-4); the organic grafted SEBS is obtained by treating SEBS resin by adopting maleic anhydride, 2-acrylamido-2-methylpropanesulfonic acid and hydroxyethyl methylacrylate. Through mutual cooperation of the raw materials, the nylon material has the advantages of high tensile strength, high elongation at break, good anticoagulation performance, good platelet adhesion resistance and high biological safety, achieves balance in mechanical properties, blood compatibility and biological safety, and meets the requirements of medical catheters.

The invention provides a platelet response type self-gelation hemostatic material as well as a preparation method and application thereof, and belongs to the field of medicines. Based on multiple cross-linking strategies such as dynamic covalent bonds and non-covalent interaction, modified sodium alginate and hydroxylated pig small intestine submucosa are used as raw materials, and the hemostatic material capable of rapidly achieving self-gelation is designed. The hemostatic material has good hydrophilicity and liquid absorption capacity, can realize powder-gelation conversion in a short time to form a stable physical barrier, has platelet response characteristics, can promote platelet adhesion, activate and accelerate the coagulation process of an organism, and improves the mechanical properties and tissue adhesion of the material, so that the hemostatic material has good application prospects. Good application prospects are realized.

This invention discloses a method for surface-modified biomaterials and a modified pericardial material, relating to the field of biomedical materials technology. The method includes the following steps: S1, providing animal pericardial material cross-linked with glutaraldehyde; providing a bridging molecule containing a first bridging group and a second bridging group, and a phosphorylcholine polymer with a third bridging group at its end; binding the first bridging group to an aldehyde group on the surface of the pericardial material via a first covalent reaction; binding the second bridging group to the third bridging group via a second covalent reaction, thereby achieving grafting of the phosphorylcholine polymer onto the material surface; the first covalent reaction and / or the second covalent reaction include Schiff base formation and reductive amination processes. The modified pericardial material prepared in this application introduces a phosphorylcholine biomimetic coating, which can improve blood compatibility on the material surface, reduce activation of the coagulation system and platelet adhesion, and inhibit the initiation of calcium ion deposition on the material surface, while exhibiting high safety.

The invention discloses a hemostatic sponge preparation method, which comprises: S1, dissolving methacrylic anhydride modified gelatin in deionized water to obtain a methacrylic acid esterified gelatin solution; s2, dissolving methacrylic anhydride modified methyl cellulose in deionized water to obtain a methacrylic acid esterified methyl cellulose solution; s3, mixing the metacrylic acid esterified gelatin solution and the metacrylic acid esterified methyl cellulose solution, and then adding a photoinitiator for photo-crosslinking to construct hydrogel with a multi-network structure; s4, the hydrogel is placed in a freeze-drying machine for freeze-drying treatment, and the hemostatic sponge of a porous structure is formed; the invention also discloses the hemostatic sponge prepared by the preparation method of the hemostatic sponge, the hemostatic sponge prepared by the preparation method of the hemostatic sponge provided by the invention has good degradability, and hydrogel with a multi-network structure is formed by introducing a double-bond chemical group and utilizing photo-crosslinking. The mechanical property and the water absorption performance of the material are remarkably improved, and platelet adhesion and hemostasis promotion are facilitated.

This invention provides a method for preparing a deep vein catheter and its inner and outer walls with zwitterionic hydrogel coatings. The catheter of this invention includes: a catheter substrate; an adhesive coating covering the inner and outer walls of the catheter; an inner wall coating and an outer wall coating (4); wherein the inner wall coating and the outer wall coating are respectively fixed to the inner and outer surfaces of the catheter substrate by the adhesive coating; and both are zwitterionic hydrogel coatings. By simultaneously constructing this hydration barrier on the inner and outer walls of the catheter, this invention can block platelet adhesion and coagulation pathway activation from the initial stage of thrombosis; at the same time, the semi-interpenetrating network or microgel-reinforced structure significantly improves the mechanical stability and durability of the hydrogel, making it suitable for long-term indwelling catheters.

The invention relates to the technical field of platelet adhesion functions, in particular to a platelet adhesion function detection system and method. The platelet adhesion function detection system comprises a detection module, the detection module comprises a detection unit, the detection unit comprises a processor, at least one analysis detection chamber and at least one standard detection chamber, in the detection process, a blood sample in the analysis detection chamber is converted into an activated state from a non-activated state, and the activated state is converted into an activated state from a non-activated state. And the processor outputs a platelet adhesion function detection result according to the change of the optical signal characteristics of the analysis detection chamber and the standard detection chamber. According to the present invention, the microfluidic technology and the turbidimetry technology are combined to achieve the automatic detection of the platelet adhesion aggregation function, such that the influence of the fibrinogen in the blood on the platelet adhesion function detection is avoided, and the accuracy of the platelet adhesion function detection is improved.

The invention relates to a filtration unit for enabling the selective leucocytapheresis of a fluid containing blood platelets. The filtration unit includes an external pouch provided with an inlet orifice and an outlet orifice, the pouch enclosing a porous element interposed between the orifices. The porous element encloses a leucocytapheresis medium impregnated with a polymer, the polymer having the general formula -(A)m-(B)n- (I), wherein A is a unit originating from an alkoxyalkyl acrylate or alkoxyalkyl methacrylate monomer, B is a unit originating from a hydrophobic polymerisable monomer, and m and n are integers, the sum of which, m+n, is equal to 100, m being an integer greater than 80.

The invention discloses a multifunctional blood compatibility coating for a medical apparatus and a preparation method and application thereof. The coating is formed by copolymerizing a functional monomer containing boron and sulfur elements and a bionic monomer containing phosphorylcholine. Wherein the boron element ensures tough adhesion of the coating on base materials such as plastic and stainless steel, and cooperates with sulfur to realize long-acting anticoagulation; as an active oxygen response unit, the sulfur element endows the coating with intelligent anti-inflammatory and anti-oxidation functions; and the phosphorylcholine structure on the outer layer can effectively resist protein and platelet adhesion. According to the invention, anticoagulation, anti-inflammation, anti-oxidation and strong adhesion functions are integrated, so that the limitation of single function and short-term effectiveness of the existing coating is overcome. The coating is suitable for blood contact instruments such as in-vivo blood sampling devices and intravascular stents, and thrombus and inflammation risks can be remarkably reduced.

The invention discloses a method for surface modification of a biological material and a modified pericardium material, and relates to the technical field of biomedical materials. The method comprises the following steps: S1, providing an animal pericardium material subjected to glutaraldehyde crosslinking treatment; providing a bridging molecule comprising a first bridging group and a second bridging group, and a phosphorylcholine polymer terminal-modified with a third bridging group; combining the first bridging group with the aldehyde group on the surface of the pericardium material through a first covalent reaction; combining the second bridging group with the third bridging group through a second covalent reaction to realize grafting of the phosphorylcholine polymer on the surface of the material; the first covalent reaction and / or the second covalent reaction comprise Schiff base formation and reductive amination processes. According to the prepared modified pericardium material, the phosphorylcholine bionic coating is introduced, the surface blood compatibility of the material can be improved, blood coagulation system activation and platelet adhesion can be reduced, deposition starting of calcium ions on the surface of the material can be inhibited, and safety is high.